XNAS
XFOR
Market cap262mUSD
Oct 08, Last price
2.79USD
1D
-0.71%
1Q
-36.73%
IPO
-99.89%
Name
X4 Pharmaceuticals Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Actelis Networks, Inc. (ASNS) is a technology company specializing in advanced networking solutions. The company designs, develops, manufactures, and markets these solutions primarily for the Internet of Things (IoT) and telecommunications industries. Its operational reach is extensive, covering North America, Latin America, Europe, the Middle East, Africa, and the Asia Pacific region. Actelis' product portfolio includes a range of essential hardware such as Ethernet access devices, high-capacity aggregation switches, broadband amplifiers, and signal repeaters. Complementing its hardware, the company also offers proprietary element management systems software. Beyond products, Actelis provides comprehensive support services, including expert consulting, technical troubleshooting, remote assistance, training programs, product repairs, and crucial software updates. These solutions cater to a diverse array of critical sectors, such as intelligent traffic systems, educational and industrial campuses, airports, smart cities, railway networks, defense, energy, oil and gas, and water utilities. Founded in 1998, Actelis Networks is headquartered in Fremont, California.
Key people
Chairman of the Board · since 2019
Co-Founder, Chairman of the Board
Renato T. Skerlj
Senior Vice President - Research and Development · since 2019
Derek Meisner
General Counsel · since 2019
Adam S. Mostafa
Chief Financial Officer, Treasurer, Assistant Secretary · since 2019
Isaac Blech
Director · since 2019
Director
Rene Russo
Director · since 2018
Murray W. Stewart
Director · since 2019
Independent Director · since 2017
Legal address
C/O THE CORPORATION TRUST COMPANY
CORPORATION TRUST CENTER 1209 ORANGE ST
WILMINGTON, DE 19801
US
CORPORATION TRUST CENTER 1209 ORANGE ST
WILMINGTON, DE 19801
US
Headquarters
955 Massachusetts Avenue
4th Floor
Cambridge, MA 02139
US
4th Floor
Cambridge, MA 02139
US
Previous name
Arsanis, Inc.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||